Real‐world effectiveness of sofosbuvir‐based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO‐03)

There are limited data regarding the real world effectiveness of direct acting antivirals (DAA) for the therapy of chronic genotype 3 hepatitis C virus (HCV) infection. All HCV genotype 3 infected patients from the German hepatitis C cohort (GECCO), which is a prospective database of nine German hep...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2018-02, Vol.90 (2), p.304-312
Hauptverfasser:	Wehmeyer, Malte H., Ingiliz, Patrick, Christensen, Stefan, Hueppe, Dietrich, Lutz, Thomas, Simon, Karl Georg, Schewe, Knud, Boesecke, Christoph, Baumgarten, Axel, Busch, Heiner, Rockstroh, Juergen, Schmutz, Guenther, Kimhofer, Torben, Berger, Florian, Mauss, Stefan, Schulze zur Wiesch, Julian
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antiviral agents Antiviral Agents - therapeutic use Antiviral drugs Chronic infection Cirrhosis daclatasvir direct acting antivirals Drug Therapy, Combination - methods Female Genotype Genotype & phenotype HCV Hepacivirus - classification Hepacivirus - genetics Hepatitis Hepatitis C Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology HIV Human immunodeficiency virus Humans Interferon ledipasvir Liver cirrhosis Male Males Middle Aged Motivation Multivariate analysis Patients Ribavirin Sexually transmitted diseases Sofosbuvir - therapeutic use STD Sustained Virologic Response Treatment Outcome Virology Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!